![]() |
|
|
1 Department of Epidemiology and 2 Department of Surgical Oncology, Roswell Park Cancer Institute, Buffalo, NY 14263 and 3 School of Medicine and Biomedical Sciences and 4 Department of Social and Preventive Medicine, University at Buffalo, Buffalo, NY 14214
* To whom correspondence should be addressed. E-mail: kirsten.moysich{at}roswellpark.org.
Obesity has been linked to increased risk of several malignancies, but the role of obesity in the etiology of ovarian cancer remains unclear. Therefore, a hospital-based case-control study was conducted to investigate the association between body size and risk of ovarian cancer. Participants included 427 women with primary, incident ovarian cancer and 854 cancer-free controls. All participants received medical services at Roswell Park Cancer Institute in Buffalo, NY between 1982 and 1998 and completed a comprehensive epidemiological questionnaire. The instrument included questions regarding height and usual wt prior to survey. Participants were classified as underweight/normal (BMI
24.9 kg/m2), overweight (BMI 25.029.9 kg/m2), or obese (BMI
30.0 kg/m2). Compared with underweight/normal participants, being overweight (adjusted odds ratio [OR] = 1.02; 95% CI 0.771.36) or obese (adjusted OR = 1.17; 95% CI 0.841.65) was not significantly associated with an elevated risk of ovarian cancer. After stratification by menopausal status, BMI showed no significant association to ovarian cancer risk among postmenopausal women (
50 y old). However, among premenopausal women (<50 y old), those classified as obese had a significantly increased risk (adjusted OR = 2.19; 95% CI 1.194.04) compared with women classified as normal/underweight. These findings suggest a potential influence of menopausal status on the total endogenous hormonal environment, including estrogens, androgens, and insulin-like growth factors, when considering the association between body size and ovarian cancer risk. In light of the fact that obesity is a modifiable risk factor, further investigation on this topic is warranted.
This article has been cited by other articles:
![]() |
P. G. Moorman, B. Calingaert, R. T. Palmieri, E. S. Iversen, R. C. Bentley, S. Halabi, A. Berchuck, and J. M. Schildkraut Hormonal Risk Factors for Ovarian Cancer in Premenopausal and Postmenopausal Women Am. J. Epidemiol., May 1, 2008; 167(9): 1059 - 1069. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Schouten, C. Rivera, D. J. Hunter, D. Spiegelman, H.-O. Adami, A. Arslan, W. L. Beeson, P. A. van den Brandt, J. E. Buring, A. R. Folsom, et al. Height, Body Mass Index, and Ovarian Cancer: A Pooled Analysis of 12 Cohort Studies Cancer Epidemiol. Biomarkers Prev., April 1, 2008; 17(4): 902 - 912. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. B. Moysich, J. A. Baker, R. J. Menezes, V. Jayaprakash, K. J. Rodabaugh, K. Odunsi, G. P. Beehler, S. E. McCann, and J. A. Villella Usual Adult Body Mass Index Is Not Predictive of Ovarian Cancer Survival Cancer Epidemiol. Biomarkers Prev., March 1, 2007; 16(3): 626 - 628. [Full Text] [PDF] |
||||